At Mays Cancer Center at 51²è¹Ý, we are revolutionizing cancer care through breakthrough research, cutting-edge treatments and a deep commitment to saving lives. Our work doesn’t stop in the lab—we bring discoveries to the patient’s bedside, ensuring the latest advancements in cancer care are accessible to those who need them most. With a multidisciplinary team of experts, we provide best-in-class therapies, giving patients and their families hope, healing and life-changing support every step of the way.
As the only National Cancer Institute (NCI)-designated Cancer Center in South Texas, the Mays Cancer Center serves a vast 38-county region with over 5 million residents. Our team of more than 300 cancer researchers and clinicians is dedicated to transforming the way cancer is diagnosed, treated and prevented—not just in San Antonio and South Texas, but worldwide.
Our 175+ active clinical trials offer patients groundbreaking new treatment options.
Pioneering Pediatric Cancer Research
The Greehey Children’s Cancer Research Institute at 51²è¹Ý is one of only two institutes in the U.S. exclusively dedicated to pediatric cancer research. Home to more than a dozen laboratories, the institute is at the forefront of cancer genomics, DNA repair, RNA biology and drug development—all with the goal of creating safer, more effective and less toxic treatments for childhood cancers.
At 51²è¹Ý, we are more than a cancer center—we are a beacon of hope, a hub of innovation and a leader in the fight against cancer.
Join us in the fight. Together, we are making a difference!
Only National Cancer Institute-designated cancer center in South Texas
300+ cancer researchers and clinicians
World-renowned Breast Cancer Symposium
In The News
51²è¹Ý of Texas Health Science Center at San Antonio (51²è¹Ý) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career investigators. Voelcker Fund Young Investigator Awards The Voelcker Fund Young Investigator Award will fund each recipient’s […]
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to 51²è¹Ý of Texas Health Science Center at San Antonio (51²è¹Ý) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment. This study analyzed utDNA from patients in the SWOG S1605 trial, who were treated with atezolizumab, an immunotherapy drug. Researchers used the UroAmp test to examine […]